Dyadic Applied BioSolutions (“Dyadic”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, ...

COO Marshall Bredwell says Perfect Day is "confident in instant profitability at plant launch" for its precision fermentation ...

Manufacture of multiple Dyadic-origin products by Fermbox Bio , enabling efficient production and market expansion of sustainable, animal-free proteins and enzymes. Dual-Sourcing flexibility, allowing ...

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of Gibco(TM) Bacto(TM) CD Supreme FPM Plus and Gibco(TM) Bacto(TM) CD Supreme Feed (2X), two ...

Kalaris Therapeutics (KLRS) announced initial data from its Phase 1a single ascending dose trial of TH103, a fully humanized, recombinant fusion ...

Dyadic Applied BioSolutions has entered into a commercial agreement with Opes Diagnosticsto support the commercial launch of Dyadic’s recombinant ...

All G is gearing up to launch its first product—recombinant bovine lactoferrin—in Q1 2026, says CEO Jan Pacas.

Proteins are the fundamental building blocks of life, and they are the essential products of molecular biology’s core dogma. Proteins play a variety of roles in the body, including catalyzing ...

The concept of a ‘plasmid’ was first introduced by Joshua Lederberg in 1952. Since that time, it has become widely recognized as a circular DNA able to viably function as a carrier for introducing a ...

The new Gibco™ Bacto™ CD Supreme FPM Plus and Feed (2X) address these needs by simplifying E. coli bioprocessing workflows and delivering predictable, high-quality results. Engineered to deliver ...